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Dear Editor,
We have read with interest the retrospective analysis by 
Pochhammer et al. [1]. The authors reported a series of 373 
patients who underwent conventional ventral hernioplasty 
with mesh augmentation in a referral hernia center. Postop-
erative C-reactive protein (CRP) measurement was consecu-
tively performed in all patients during the hospital course. 
Prevalence of postoperative infectious complications (ICs) 
was 13.7% (n = 51). Authors reported positive predictive val-
ues (PPV) and negative predictive values (NPV) at different 
postoperative days (POD). PPVs and NPVs for POD 2/3 
and POD were 0.29–0.46 and 1.00–0.93, respectively. The 
authors concluded that postoperative serum CRP allows for 
early prediction of the postoperative course with low CRP 
values being associated with reduced risk of ICs.
We congratulate the authors for the idea to investigate 
the postoperative CRP predictive value in the diagnosis of 
ICs after mesh-reinforced ventral hernioplasty. This paper 
strengthens and broadens this concept previously investi-
gated in other general surgery settings [2–4]. After carefully 
reading, CRP seems to be a useful biomarker to rule out 
postoperative ICs. This is supported by the estimated low 
POD 2/3 and POD 5/6 PPVs (0.29–0.46, respectively) and 
high NPVs (1.00 and 0.93, respectively). It is true that PPV 
and NPV are influenced by the disease prevalence (prior 
probability) but having such high estimated NPVs (> 0.90), 
results are less affected by disease prevalence.
We thank the authors for their remarkable work and for 
having added further empirical evidence that confirms the 
emerging role of postoperative CRP predictive values. Sup-
ported by previous published evidence and authors’ data, 
CRP may have a diagnostic role with a high level of con-
fidence. In conclusion, CRP should not be interpreted as 
marker to diagnose but rather as a useful tool to rule out a 
diagnosis. However, postoperative CRP should not be con-
sidered a panacea, but in conjunction with reassuring clini-
cal signs it may be an additional arrow in each surgeon’s 
quiver.
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